San Antonio-The board of directors for Houston-based immunotherapy biotech Kiromic has decided against taking a $200,000 investment from San Antonio-based economic development group, which would have required the company to relocate to San Antonio.
The company still plans to have a presence in San Antonio, including leasing commercial space, according to Ed Davis, the executive director of the San Antonio Economic Development Corporation, which was seeking $200,000 worth of preferred equity in Kiromic’s Series A round of funding. Kiromic has artificial intelligence software that it’s using to develop two experimental cancer immunotherapies. The company is trying to raise a $12… Read more »
UNDERWRITERS AND PARTNERS